caffeine has been researched along with Tachycardia, Ventricular in 34 studies
Tachycardia, Ventricular: An abnormally rapid ventricular rhythm usually in excess of 150 beats per minute. It is generated within the ventricle below the BUNDLE OF HIS, either as autonomic impulse formation or reentrant impulse conduction. Depending on the etiology, onset of ventricular tachycardia can be paroxysmal (sudden) or nonparoxysmal, its wide QRS complexes can be uniform or polymorphic, and the ventricular beating may be independent of the atrial beating (AV dissociation).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited disease characterized by life threatening arrhythmias and mutations in the gene encoding the ryanodine receptor (RyR2)." | 3.73 | Arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia: insights from a RyR2 R4496C knock-in mouse model. ( Colombi, B; Imbriani, M; Lai, FA; Liu, N; Memmi, M; Napolitano, C; Negri, S; Priori, SG; Rizzi, N; Zissimopoulos, S, 2006) |
| "Ventricular ectopic beats are commonly seen in daily clinical practice." | 2.48 | RETRACTED: Ventricular Ectopic Beats: An Overview of Management Considerations ( Chockalingam, A; Ingole, A; Jadhav, A, 2012) |
| "Serious complications included 2 seizures and 1 episode of ventricular tachycardia." | 1.48 | Energy drink exposures reported to Texas poison centers: Analysis of adverse incidents in relation to total sales, 2010-2014. ( Baeza, S; Borron, SW; Herrera, J; Kingston, RL; Larson, J; Watts, SH, 2018) |
| "Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited arrhythmia characterized by syncope and sudden death occurring during exercise or acute emotion." | 1.42 | Functional abnormalities in iPSC-derived cardiomyocytes generated from CPVT1 and CPVT2 patients carrying ryanodine or calsequestrin mutations. ( Arad, M; Barad, L; Binah, O; Eisen, B; Eldar, M; Eldor, L; Gherghiceanu, M; Itskovitz-Eldor, J; Lorber, A; Novak, A; Reiter, I, 2015) |
| "Caffeine is an easily available drug which is generally regarded as being safe." | 1.40 | Caffeine intoxication successfully treated by hemoperfusion and hemodialysis. ( Fukasawa, H; Furuya, R; Ishigaki, S; Kinoshita-Katahashi, N; Kumagai, H; Yasuda, H, 2014) |
| "Catecholaminergic polymorphic ventricular tachycardia (CPVT) is caused by mutations in cardiac ryanodine receptor (RyR2) or calsequestrin (Casq2) genes." | 1.39 | Accelerated sinus rhythm prevents catecholaminergic polymorphic ventricular tachycardia in mice and in patients. ( Faggioni, M; Hwang, HS; Kannankeril, PJ; Knollmann, BC; Nederend, I; van der Werf, C; Wilde, AA, 2013) |
| "Paroxysmal supraventricular tachycardia (PSVT) on electrocardiographic monitoring was found." | 1.38 | Severe acute caffeine poisoning due to intradermal injections: mesotherapy hazard. ( Aćimović, L; Babić, G; Ercegović, GV; Janković, S; Segrt, Z; Vukcević, NP, 2012) |
| "Catecholaminergic polymorphic ventricular tachycardia (CPVT) is caused by a single point mutation in a well-defined region of the cardiac type 2 ryanodine receptor (RyR)2." | 1.36 | Catecholaminergic polymorphic ventricular tachycardia is caused by mutation-linked defective conformational regulation of the ryanodine receptor. ( Doi, M; Ikeda, Y; Ikemoto, N; Kobayashi, S; Matsuzaki, M; Oda, T; Ohkusa, T; Okuda, S; Ono, M; Suetomi, T; Tateishi, H; Uchinoumi, H; Xu, X; Yamamoto, T; Yano, M, 2010) |
| "Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited disease characterized by adrenergically mediated polymorphic ventricular tachycardia leading to syncope and sudden cardiac death." | 1.33 | Bidirectional ventricular tachycardia and fibrillation elicited in a knock-in mouse model carrier of a mutation in the cardiac ryanodine receptor. ( Cerrone, M; Colombi, B; di Barletta, MR; Napolitano, C; Priori, SG; Santoro, M; Scelsi, M; Villani, L, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (5.88) | 18.2507 |
| 2000's | 16 (47.06) | 29.6817 |
| 2010's | 15 (44.12) | 24.3611 |
| 2020's | 1 (2.94) | 2.80 |
| Authors | Studies |
|---|---|
| Harsten, R | 1 |
| Tetlow, SJ | 1 |
| Chan, T | 1 |
| Ankuli, A | 1 |
| Zhong, X | 2 |
| Vallmitjana, A | 2 |
| Sun, B | 1 |
| Xiao, Z | 1 |
| Guo, W | 1 |
| Wei, J | 1 |
| Ni, M | 1 |
| Chen, Y | 1 |
| O'Brien, ER | 1 |
| Gillis, AM | 1 |
| Hoshijima, M | 1 |
| Takeshima, H | 1 |
| Hove-Madsen, L | 2 |
| Benitez, R | 2 |
| Belke, D | 1 |
| Wayne Chen, SR | 1 |
| Borron, SW | 1 |
| Watts, SH | 1 |
| Herrera, J | 1 |
| Larson, J | 1 |
| Baeza, S | 1 |
| Kingston, RL | 1 |
| Sahashi, Y | 1 |
| Naruse, G | 1 |
| Okura, H | 1 |
| Zhang, XH | 1 |
| Haviland, S | 1 |
| Wei, H | 1 |
| Sarić, T | 1 |
| Fatima, A | 1 |
| Hescheler, J | 1 |
| Cleemann, L | 1 |
| Morad, M | 1 |
| Bai, Y | 1 |
| Jones, PP | 1 |
| Guo, J | 1 |
| Clark, RB | 1 |
| Zhou, Q | 1 |
| Wang, R | 1 |
| Semeniuk, L | 1 |
| Guo, A | 1 |
| Song, LS | 1 |
| Duff, HJ | 1 |
| Chen, SR | 2 |
| Ishigaki, S | 1 |
| Fukasawa, H | 1 |
| Kinoshita-Katahashi, N | 1 |
| Yasuda, H | 1 |
| Kumagai, H | 1 |
| Furuya, R | 1 |
| Tsai, WC | 1 |
| Lu, YY | 1 |
| Chen, YC | 1 |
| Chang, CJ | 1 |
| Kao, YH | 1 |
| Lin, YK | 1 |
| Chen, YH | 1 |
| Chen, SA | 1 |
| Yang, LY | 1 |
| Chen, YJ | 1 |
| Novak, A | 1 |
| Barad, L | 1 |
| Lorber, A | 1 |
| Gherghiceanu, M | 1 |
| Reiter, I | 1 |
| Eisen, B | 1 |
| Eldor, L | 1 |
| Itskovitz-Eldor, J | 1 |
| Eldar, M | 1 |
| Arad, M | 1 |
| Binah, O | 1 |
| Laskowski, LK | 1 |
| Henesch, JA | 1 |
| Nelson, LS | 1 |
| Hoffman, RS | 1 |
| Smith, SW | 1 |
| Richards, JR | 1 |
| Ramoska, EA | 1 |
| Sand, IC | 1 |
| Cua, WL | 1 |
| Pease Campbell, JA | 1 |
| Stewart, JT | 1 |
| Fernández-Velasco, M | 1 |
| Rueda, A | 1 |
| Rizzi, N | 2 |
| Benitah, JP | 1 |
| Colombi, B | 3 |
| Napolitano, C | 3 |
| Priori, SG | 3 |
| Richard, S | 1 |
| Gómez, AM | 1 |
| Uchinoumi, H | 1 |
| Yano, M | 1 |
| Suetomi, T | 1 |
| Ono, M | 1 |
| Xu, X | 1 |
| Tateishi, H | 1 |
| Oda, T | 1 |
| Okuda, S | 1 |
| Doi, M | 1 |
| Kobayashi, S | 1 |
| Yamamoto, T | 1 |
| Ikeda, Y | 1 |
| Ohkusa, T | 1 |
| Ikemoto, N | 1 |
| Matsuzaki, M | 1 |
| Jadhav, A | 1 |
| Ingole, A | 1 |
| Chockalingam, A | 1 |
| Shan, J | 1 |
| Xie, W | 1 |
| Betzenhauser, M | 1 |
| Reiken, S | 1 |
| Chen, BX | 1 |
| Wronska, A | 1 |
| Marks, AR | 1 |
| Vukcević, NP | 1 |
| Babić, G | 1 |
| Segrt, Z | 1 |
| Ercegović, GV | 1 |
| Janković, S | 1 |
| Aćimović, L | 1 |
| Faggioni, M | 1 |
| Hwang, HS | 1 |
| van der Werf, C | 1 |
| Nederend, I | 1 |
| Kannankeril, PJ | 2 |
| Wilde, AA | 1 |
| Knollmann, BC | 1 |
| Jiang, D | 1 |
| Xiao, B | 1 |
| Zhang, L | 1 |
| George, CH | 2 |
| Higgs, GV | 1 |
| Lai, FA | 3 |
| Goldhaber, JI | 1 |
| Xie, LH | 1 |
| Duong, T | 1 |
| Motter, C | 1 |
| Khuu, K | 1 |
| Weiss, JN | 1 |
| Cerrone, M | 1 |
| Santoro, M | 1 |
| di Barletta, MR | 1 |
| Scelsi, M | 1 |
| Villani, L | 1 |
| Nam, GB | 1 |
| Burashnikov, A | 1 |
| Antzelevitch, C | 1 |
| Balasubramaniam, R | 1 |
| Chawla, S | 1 |
| Grace, AA | 1 |
| Huang, CL | 1 |
| Jundi, H | 1 |
| Walters, N | 1 |
| Thomas, NL | 1 |
| West, RR | 1 |
| Liu, N | 1 |
| Memmi, M | 1 |
| Zissimopoulos, S | 1 |
| Negri, S | 1 |
| Imbriani, M | 1 |
| Mitchell, BM | 1 |
| Goonasekera, SA | 1 |
| Chelu, MG | 1 |
| Zhang, W | 1 |
| Sood, S | 1 |
| Kearney, DL | 1 |
| Danila, CI | 1 |
| De Biasi, M | 1 |
| Wehrens, XH | 1 |
| Pautler, RG | 1 |
| Roden, DM | 1 |
| Taffet, GE | 1 |
| Dirksen, RT | 1 |
| Anderson, ME | 1 |
| Hamilton, SL | 1 |
| Ng, GA | 1 |
| Paavola, J | 1 |
| Viitasalo, M | 1 |
| Laitinen-Forsblom, PJ | 1 |
| Pasternack, M | 1 |
| Swan, H | 1 |
| Tikkanen, I | 1 |
| Toivonen, L | 1 |
| Kontula, K | 1 |
| Laine, M | 1 |
| Dirksen, WP | 1 |
| Lacombe, VA | 1 |
| Chi, M | 1 |
| Kalyanasundaram, A | 1 |
| Viatchenko-Karpinski, S | 1 |
| Terentyev, D | 1 |
| Zhou, Z | 1 |
| Vedamoorthyrao, S | 1 |
| Li, N | 1 |
| Chiamvimonvat, N | 1 |
| Carnes, CA | 1 |
| Franzini-Armstrong, C | 1 |
| Györke, S | 1 |
| Periasamy, M | 1 |
| Fujiyoshi, N | 1 |
| Yoshioka, T | 1 |
| Morimoto, F | 1 |
| Suzuki, Y | 1 |
| Sueyoshi, K | 1 |
| Shibuya, M | 1 |
| Shimazaki, J | 1 |
| Ishida, S | 1 |
| Ito, M | 1 |
| Takahashi, N | 1 |
| Fujino, T | 1 |
| Akimitsu, T | 1 |
| Saikawa, T | 1 |
| Aizaki, T | 1 |
| Osaka, M | 1 |
| Hara, H | 1 |
| Kurokawa, S | 1 |
| Matsuyama, K | 1 |
| Aoyama, N | 1 |
| Soma, K | 1 |
| Ohwada, T | 1 |
| Izumi, T | 1 |
| Marchlinski, FE | 1 |
| Deely, MP | 1 |
| Zado, ES | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Myocarditis Causing Premature Ventricular Contractions:Insights From the MAVERIC Registry[NCT05158751] | 100 participants (Anticipated) | Observational | 2023-01-31 | Not yet recruiting | |||
| Role of a Novel Implantable Loop Recorder in the Management of Premature Ventricular Contractions[NCT06060548] | 50 participants (Anticipated) | Observational | 2022-04-20 | Recruiting | |||
| Risk Stratifications for Patients Come With Palpitations in Assiut and Suez Canal University Hospitals[NCT06103305] | 208 participants (Anticipated) | Observational | 2023-10-31 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for caffeine and Tachycardia, Ventricular
| Article | Year |
|---|---|
RETRACTED: Ventricular Ectopic Beats: An Overview of Management Considerations
Topics: Caffeine; Catheter Ablation; Exercise; Heart Ventricles; Humans; Hypertension; Prevalence; Tachycard | 2012 |
Treating patients with ventricular ectopic beats.
Topics: Caffeine; Cardiomegaly; Electrocardiography; Exercise; Humans; Hypertension; Prognosis; Tachycardia, | 2006 |
Treating patients with ventricular ectopic beats.
Topics: Caffeine; Cardiomegaly; Electrocardiography; Exercise; Humans; Hypertension; Prognosis; Tachycardia, | 2006 |
Treating patients with ventricular ectopic beats.
Topics: Caffeine; Cardiomegaly; Electrocardiography; Exercise; Humans; Hypertension; Prognosis; Tachycardia, | 2006 |
Treating patients with ventricular ectopic beats.
Topics: Caffeine; Cardiomegaly; Electrocardiography; Exercise; Humans; Hypertension; Prognosis; Tachycardia, | 2006 |
Treating patients with ventricular ectopic beats.
Topics: Caffeine; Cardiomegaly; Electrocardiography; Exercise; Humans; Hypertension; Prognosis; Tachycardia, | 2006 |
Treating patients with ventricular ectopic beats.
Topics: Caffeine; Cardiomegaly; Electrocardiography; Exercise; Humans; Hypertension; Prognosis; Tachycardia, | 2006 |
Treating patients with ventricular ectopic beats.
Topics: Caffeine; Cardiomegaly; Electrocardiography; Exercise; Humans; Hypertension; Prognosis; Tachycardia, | 2006 |
Treating patients with ventricular ectopic beats.
Topics: Caffeine; Cardiomegaly; Electrocardiography; Exercise; Humans; Hypertension; Prognosis; Tachycardia, | 2006 |
Treating patients with ventricular ectopic beats.
Topics: Caffeine; Cardiomegaly; Electrocardiography; Exercise; Humans; Hypertension; Prognosis; Tachycardia, | 2006 |
[Case of caffeine poisoning survived by percutaneous cardio-pulmonary support].
Topics: Adolescent; Caffeine; Cardiopulmonary Resuscitation; Electric Countershock; Female; Humans; Tachycar | 2008 |
31 other studies available for caffeine and Tachycardia, Ventricular
| Article | Year |
|---|---|
Intralipid and haemodialysis in caffeine overdose.
Topics: Acidosis; Adult; Anti-Arrhythmia Agents; Caffeine; Drug Overdose; Emulsions; Fat Emulsions, Intraven | 2020 |
Reduced expression of cardiac ryanodine receptor protects against stress-induced ventricular tachyarrhythmia, but increases the susceptibility to cardiac alternans.
Topics: Action Potentials; Animals; Caffeine; Calcium; Calcium Signaling; Cardiomegaly; Death, Sudden, Cardi | 2018 |
Energy drink exposures reported to Texas poison centers: Analysis of adverse incidents in relation to total sales, 2010-2014.
Topics: Caffeine; Child; Child, Preschool; Commerce; Energy Drinks; Female; Humans; Male; Retrospective Stud | 2018 |
Three Different Types of Tachyarrhythmia and QT Prolongation in a Suicide Attempt.
Topics: Action Potentials; Atrial Fibrillation; Caffeine; Drug Overdose; Electrocardiography; Female; Heart | 2019 |
Ca2+ signaling in human induced pluripotent stem cell-derived cardiomyocytes (iPS-CM) from normal and catecholaminergic polymorphic ventricular tachycardia (CPVT)-afflicted subjects.
Topics: Adrenergic Agonists; Adult; Caffeine; Calcium; Calcium Signaling; Catecholamines; Cell Differentiati | 2013 |
Phospholamban knockout breaks arrhythmogenic Ca²⁺ waves and suppresses catecholaminergic polymorphic ventricular tachycardia in mice.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2013 |
Caffeine intoxication successfully treated by hemoperfusion and hemodialysis.
Topics: Adult; Caffeine; Central Nervous System Stimulants; Hemoperfusion; Humans; Male; Renal Dialysis; Sch | 2014 |
Ablation of androgen receptor gene triggers right ventricular outflow tract ventricular tachycardia.
Topics: Action Potentials; Adenosine; Animals; Caffeine; Calcium; Flecainide; Gene Knockdown Techniques; Gen | 2015 |
Functional abnormalities in iPSC-derived cardiomyocytes generated from CPVT1 and CPVT2 patients carrying ryanodine or calsequestrin mutations.
Topics: Base Sequence; Caffeine; Calcium Signaling; Calsequestrin; Cell Differentiation; Genotyping Techniqu | 2015 |
Start me up! Recurrent ventricular tachydysrhythmias following intentional concentrated caffeine ingestion.
Topics: Adrenergic beta-Antagonists; Caffeine; Dietary Supplements; Electric Countershock; Electrocardiograp | 2015 |
Beta-blocker treatment of caffeine-induced tachydysrhythmias.
Topics: Adrenergic beta-Antagonists; Caffeine; Catecholamines; Humans; Propanolamines; Tachycardia, Ventricu | 2016 |
A case of ventricular tachycardia related to caffeine pretreatment.
Topics: Aged; Bipolar Disorder; Caffeine; Convulsants; Electroconvulsive Therapy; Humans; Male; Premedicatio | 2009 |
Increased Ca2+ sensitivity of the ryanodine receptor mutant RyR2R4496C underlies catecholaminergic polymorphic ventricular tachycardia.
Topics: Adrenergic beta-Agonists; Animals; Caffeine; Calcium Signaling; Cardiac Pacing, Artificial; Catechol | 2009 |
Catecholaminergic polymorphic ventricular tachycardia is caused by mutation-linked defective conformational regulation of the ryanodine receptor.
Topics: Animals; Caffeine; Calcium Signaling; Cells, Cultured; Cyclic AMP-Dependent Protein Kinases; Disease | 2010 |
Calcium leak through ryanodine receptors leads to atrial fibrillation in 3 mouse models of catecholaminergic polymorphic ventricular tachycardia.
Topics: Animals; Atrial Fibrillation; Caffeine; Calcium; Cardiac Pacing, Artificial; Cells, Cultured; Diseas | 2012 |
Severe acute caffeine poisoning due to intradermal injections: mesotherapy hazard.
Topics: Caffeine; Electrocardiography; Female; Humans; Injections, Intradermal; Mesotherapy; Middle Aged; Ob | 2012 |
Accelerated sinus rhythm prevents catecholaminergic polymorphic ventricular tachycardia in mice and in patients.
Topics: Adult; Animals; Atropine; Bradycardia; Caffeine; Calcium Signaling; Calsequestrin; Cardiac Pacing, A | 2013 |
Enhanced basal activity of a cardiac Ca2+ release channel (ryanodine receptor) mutant associated with ventricular tachycardia and sudden death.
Topics: Animals; Caffeine; Calcium; Calcium Signaling; Cell Line; Death, Sudden, Cardiac; Electric Conductiv | 2002 |
Ryanodine receptor mutations associated with stress-induced ventricular tachycardia mediate increased calcium release in stimulated cardiomyocytes.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Caffeine; Calcium; Cell Line; Cresols; Humans; Isoprote | 2003 |
Action potential duration restitution and alternans in rabbit ventricular myocytes: the key role of intracellular calcium cycling.
Topics: Action Potentials; Animals; Caffeine; Calcium; Calcium Channels; Calcium Channels, L-Type; Calcium S | 2005 |
Bidirectional ventricular tachycardia and fibrillation elicited in a knock-in mouse model carrier of a mutation in the cardiac ryanodine receptor.
Topics: Animals; Caffeine; Disease Models, Animal; Electrocardiography; Epinephrine; Mice; Mutation; Ryanodi | 2005 |
Cellular mechanisms underlying the development of catecholaminergic ventricular tachycardia.
Topics: Action Potentials; Animals; Caffeine; Calcium; Catecholamines; Disease Models, Animal; Dogs; Dose-Re | 2005 |
Caffeine-induced arrhythmias in murine hearts parallel changes in cellular Ca(2+) homeostasis.
Topics: Animals; Caffeine; Calcium; Calcium Channel Blockers; Cytosol; Diltiazem; Electric Stimulation; Home | 2005 |
Arrhythmogenic mutation-linked defects in ryanodine receptor autoregulation reveal a novel mechanism of Ca2+ release channel dysfunction.
Topics: Animals; Arrhythmias, Cardiac; Caffeine; Calcium; CHO Cells; Cricetinae; Death, Sudden, Cardiac; Flu | 2006 |
Arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia: insights from a RyR2 R4496C knock-in mouse model.
Topics: Animals; Arrhythmias, Cardiac; Caffeine; Cells, Cultured; Epinephrine; Membrane Potentials; Mice; Mi | 2006 |
Mice with the R176Q cardiac ryanodine receptor mutation exhibit catecholamine-induced ventricular tachycardia and cardiomyopathy.
Topics: Animals; Caffeine; Cardiomyopathies; Catecholamines; Central Nervous System Stimulants; Epinephrine; | 2006 |
Mutant ryanodine receptors in catecholaminergic polymorphic ventricular tachycardia generate delayed afterdepolarizations due to increased propensity to Ca2+ waves.
Topics: Action Potentials; Adrenergic Agonists; Adult; Caffeine; Calcium; Central Nervous System Stimulants; | 2007 |
A mutation in calsequestrin, CASQ2D307H, impairs Sarcoplasmic Reticulum Ca2+ handling and causes complex ventricular arrhythmias in mice.
Topics: Animals; Caffeine; Calcium; Calcium Signaling; Calsequestrin; Cardiotonic Agents; Death, Sudden, Car | 2007 |
Caffeine induces ventricular tachyarrhythmias possibly due to triggered activity in rabbits in vivo.
Topics: Animals; Blood Pressure; Caffeine; Calcium Channel Blockers; Catecholamines; Cyclic AMP; Drug Evalua | 1996 |
Hypokalemia with syncope caused by habitual drinking of oolong tea.
Topics: Binding Sites; Caffeine; Electrocardiography; Feeding Behavior; Female; Follow-Up Studies; Heart Blo | 1999 |
Sex-specific triggers for right ventricular outflow tract tachycardia.
Topics: Adult; Aged; Bundle-Branch Block; Caffeine; Central Nervous System Stimulants; Contraceptive Agents, | 2000 |